Variant report
Variant | nsv874032 |
---|---|
Chromosome Location | chr2:50434741-50449138 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs551329314 | chr2:50435003-50435004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs111371785 | chr2:50435042-50435043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143639296 | chr2:50435043-50435044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552910764 | chr2:50435048-50435049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs7559336 | chr2:50435064-50435065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs558010018 | chr2:50435122-50435123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs188296322 | chr2:50435138-50435139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs180699809 | chr2:50435155-50435156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs73930314 | chr2:50435173-50435174 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs546375271 | chr2:50435189-50435190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs540898111 | chr2:50435193-50435194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183743971 | chr2:50435219-50435220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572933631 | chr2:50435256-50435257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540345910 | chr2:50435317-50435318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs561640710 | chr2:50435320-50435321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs17040212 | chr2:50435324-50435325 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs188853197 | chr2:50435342-50435343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181203749 | chr2:50435347-50435348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs6545156 | chr2:50435355-50435356 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs551509279 | chr2:50435357-50435358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs371855895 | chr2:50435360-50435361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs185208250 | chr2:50442219-50442220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567185920 | chr2:50442228-50442229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs527839022 | chr2:50442249-50442250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs190900530 | chr2:50442274-50442275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs6724128 | chr2:50442276-50442277 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs113138873 | chr2:50442284-50442285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs376143474 | chr2:50442287-50442288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs555721577 | chr2:50442312-50442313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570885862 | chr2:50442389-50442390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183010230 | chr2:50442470-50442471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553611711 | chr2:50442473-50442474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs148169702 | chr2:50442527-50442528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542455944 | chr2:50442547-50442548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141973534 | chr2:50442548-50442549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs57241326 | chr2:50442568-50442569 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs567274458 | chr2:50442570-50442571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs562992186 | chr2:50442593-50442594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs150691688 | chr2:50442611-50442612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186339851 | chr2:50442631-50442632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560719212 | chr2:50442668-50442669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs550398543 | chr2:50442679-50442680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191138625 | chr2:50442685-50442686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567879424 | chr2:50442697-50442698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs183194673 | chr2:50442704-50442705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570162850 | chr2:50442712-50442713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187440896 | chr2:50442727-50442728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs549432518 | chr2:50442731-50442732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571020926 | chr2:50442773-50442774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538201919 | chr2:50442780-50442781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Psychiatric disorder | 19734545 | CNVD |
Autism | 20844286 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Autism | 19218893 | CNVD |
Autism | 22209245 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Schizophrenia | 22118685 | CNVD |
Autism | 20663923 | CNVD |
Schizophrenia | 21285140 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21990379 | CNVD |
Schizophrenia | 22885689 | CNVD |
Autism | 20964600 | CNVD |
Schizophrenia | 19521646 | CNVD |
Attention deficit hyperactivity disorder | 22214315 | CNVD |
Chronic motor tic disorder | 22214315 | CNVD |
Schizophrenia | 22214315 | CNVD |
Mental retardation | 19896112 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:50435000-50435400 | Enhancers | Aorta | Aorta |
2 | chr2:50442200-50444000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |